Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Global Calcium Pvt. Limited
WARNING LETTER
•Global Calcium Pvt. Limited•August 2, 2024

Global Calcium Pvt. Limited – FDA Warning Letter, Aug 2, 2024

Record Details

The FDA issued a Warning Letter to Global Calcium Pvt. Limited following an inspection from July 29 to August 2, 2024, at their Hosur, India facility, identifying significant CGMP deviations for active pharmaceutical ingredients (APIs), rendering their products adulterated.

Key violations include: 1. **Failure of the quality unit to prepare, review, and approve documents:** Production records showed simultaneous manufacturing of different APIs on the same equipment. Multiple electronic records were deleted during the inspection, which the company admitted was to "avoid unwanted conversation" and that falsified records were created to claim production incentives. The company's response was deemed inadequate, as their quality impact assessment relied on deficient data, and they failed to adequately address the extent of record fabrication or reconcile all CGMP records. 2. **Failure to properly maintain buildings and facilities:** Investigators observed liquid dripping from a ceiling pipe onto processing equipment labeled as clean. The company's response was inadequate, failing to address potential contamination of previously manufactured lots or provide evidence of a comprehensive facility evaluation. 3. **Failure to establish a comprehensive impurity profile:** The company's impurity profiles for APIs were incomplete, only listing USP-described impurities without considering their unique processes. Impurities were also not monitored during stability studies. The company's response was inadequate, as they had received returned products due to quality issues and failed to provide a retroactive risk assessment or communicate updated profiles to customers.

The FDA recommends engaging a

Company
Global Calcium Pvt. Limited
Inspection date
August 2, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 6f7dfe68-9bec-499e-b09a-5960a1af8797

Violation Codes5
21 U.S.C. 351(a)(2)(B)FD&C Act 501(a)(2)(B)21 U.S.C. 381(a)(3)FD&C Act 801(a)(3)21 U.S.C. 356C(b)

Full citation text and observation details available on the Dashboard.

Other documents for Global Calcium Pvt. Limited
  • 483 - 2026-02-03February 3, 2026
  • 483 - 2024-08-02August 2, 2024
  • 483 - 2019-02-22February 22, 2019
  • 483 - 2015-04-06April 6, 2015
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Global Calcium Pvt. Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.